Cutaneous T-cell lymphoma in Kuwait: a retrospective analysis of treatment modalities and prognostic factors
- 6 January 2026
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 123 (5) , 720-726
Abstract
Background Cutaneous T-cell lymphoma (CTCL) is a rare malignancy with limited data available from the Middle East. This study evaluated the clinical characteristics, treatment patterns, and outcomes of CTCL patients treated in Kuwait. Methods This was a retrospective review of all adult patients diagnosed between February 2021 and March 2024. Data included demographics, staging, treatment modalities, and outcomes. Kaplan–Meier analysis was used to evaluate progression-free survival (PFS) and overall survival (OS). Results The study included 86 patients. The mean age at diagnosis was 44 years (range: 16–80), and 84% of patients presented with early-stage disease (IA–IIA). NB-UVB phototherapy was the most common treatment for early-stage disease, while brentuximab vedotin was frequently used for advanced diseases. Median OS was 30 months in patients with advanced disease and not reached in those with early-stage disease (p = 0.003). Median PFS was 22 months overall, and significantly longer in early-stage than advanced disease (50 vs. 15 months, p = 0.009). Advanced stage, blood involvement, and elevated LDH were significant predictors of worse PFS. Conclusion This study provides the first real-world analysis of CTCL outcomes in Kuwait. The findings underscore the importance of early detection and the role of novel therapies in disease management.Keywords
This publication has 18 references indexed in Scilit:
- [Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell LymphomasActas Dermo-Sifiliograficas, 2024
- Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of QuebecAnnales de Dermatologie et de Vénéréologie, 2023
- EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023European Journal of Cancer, 2023
- Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year reviewJournal of the American Academy of Dermatology, 2022
- The PROCLIPI international registry, an important tool to evaluate the prognosis of cutaneous T cell lymphomasLa Presse Médicale, 2022
- Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohortInternational Journal of Dermatology, 2021
- Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?Journal of Investigative Dermatology, 2020
- British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018British Journal of Dermatology, 2018
- Prognostic indicators for mycosis fungoides in a Greek populationBritish Journal of Dermatology, 2017
- Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991–2006International Journal of Dermatology, 2010